(Q72799644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

In vitro activity of norfloxacin against Mycoplasma hominis and Ureaplasma urealyticum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

In vitro activity of norfloxacin againstMycoplasma hominis andUreaplasma urealyticum (English)

1 reference

2 September 2023

1 reference

Ureaplasma urealyticum

1 reference

1 reference

2 September 2023

author name string

C. Simon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6227484

2 September 2023

U. Lindner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6227484

2 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6227484

2 September 2023

publication date

1 October 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

http://link.springer.com/content/pdf/10.1007/BF02013911.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02013911/fulltext.html

2 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF02013911

2 September 2023

1 reference

European journal of clinical microbiology

2 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

479-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

Modifications of the growth inhibition test and its application to human T-mycoplasmas

29 October 2019

cites work

1 reference

12 December 2020

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

1 reference

12 December 2020

Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents

1 reference

12 December 2020

Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids

1 reference

12 December 2020

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6227484%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference